The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
Takeshi Iwata, Division Director at the National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, tells us about advancing research and developing new therapies for inherited retinal eye diseases.
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
In this article, the health impact of when you don't sleep for days is explored: Find out what happens to you cognitively, physically, mentally and hormonally.
Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
A new study in the Journal of Medicinal Food has investigated whether the contents of a cup of green tea could have specific calming properties after a stressful experience.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
We spoke with Prof Benedetta Allegranzi at the World Health Organization (WHO) to find out about the importance of implementing infection prevention and control (IPC) programmes to reduce healthcare-associated infection (HCAI) and sepsis worldwide.
Laura Hagerty, PhD, Scientific Portfolio Director at the Muscular Dystrophy Association, highlights strategies for gene correction to treat Duchenne muscular dystrophy.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group gives an overall perspective on the challenges and concerns around acute promyelocytic leukaemia (APL), a type of blood cancer.
Dineke Zeegers Paget, Executive Director of the European Public Health Association (EUPHA) believes that there is a vital need for strong guidance in public health at the European level and as such, nobody should be left behind.
